Developmental and thyroidal regulation of the nuclear T3 receptors/c-erb A oncogene products in the Ob 17 preadipocyte cell line.
In a thyroid hormone-sensitive mouse preadipocyte cell line (Ob 17), the concentration of nuclear T3 receptors increases during differentiation in an insulin-independent manner and decreases by 50-60 p.cent after medium supplementation with physiological concentrations of T3. The down-regulation of T3 receptors implies both quantitative and qualitative changes. The preadipocyte T3 receptors were previously reported to be heterogeneous in gel filtration and in their reactivity towards rabbit antibodies raised against large erb A alpha peptides. This report shows that the receptor heterogeneity is not modified during cell development, whereas T3 mainly depletes the receptor species that are both the most retarded in gel filtration and preferentially recognized by c-erb A alpha-specific antisera. The c-erb A alpha-related T3 receptors which predominate in preadipocytes, are thus probably mainly involved in receptor depletion by T3. A similar T3 receptor half-life of 12-13 h was estimated after cycloheximide addition to cells at confluence or later in the differentiation phase with or without T3. This suggested that development, or T3, might have mainly affected the production of T3 receptors. In Northern hybridization studies, using alpha- or beta-type c-erb A cDNA probes containing the entire coding sequence, only alpha-type mRNAs were detected with a predominant band of 2.8 kbases and two fainter bands of about 5.5 and 6.0 kbases. The alpha-type mRNA abundance relative to beta-actin significantly increased during differentiation and decreased after T3 addition.
Teboul
M
M
INSERM Unité 38, CNRS URA 178, Faculté de Médecine, Marseille, France.
Bismuth
J
J
Ghiringhelli
O
O
Bonne
J
J
Torresani
J
J
D000273:Adipose Tissue / Q000737:chemistry*; D000818:Animals; D002454:Cell Differentiation; D002460:Cell Line; D002467:Cell Nucleus / Q000737:chemistry*; D006207:Half-Life; D051379:Mice; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D011988:Receptors, Thyroid Hormone / Q000032:analysis* / Q000235:genetics; D014284:Triiodothyronine / Q000494:pharmacology*
D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D011988:Receptors, Thyroid Hormone; D014284:Triiodothyronine